Variant: 6-32478685-MEI-SVA

Allele Count: 737
Allele Number: 19320
Allele Frequency: 0.0381
SVTYPE: Retroposon/SVA
MEI: SVA_F
START (0-based): 32478685
END (0-based): 32478733
SVLEN: 590
MESTRAND: -
Number of Homozygotes: 44
Reference: T2T-CHM13

T2T-specific: 6:32472837-32480832

Browser:
Region annotation
RegionGene IDGene Detail
RefSeqintergenicHLA-DQA1;HLA-DQB1dist=5920;dist=3759

Allele frequency distribution

xQTL Plot

xQTL results for 6-32478685-MEI-SVA

Linkage Disequilibrium Plot

LD results for 6-32478685-MEI-SVA

The R2 statistic is the correlation coefficient of genotypes between pairs of loci. D' is the normalized LD statistic by dividing LD statistic D by its theoretical maximum, while D = pAB - pA * pB.
GWAS Catalog
LD SNPLD R2Risk AlleleGeneTrait ClassTraitOR/BetaP-valueStudyAncestry
6-32435139-C-TAFR:0.28 AMR:0.21 EAS:0.62 EUR:0.22 SAS:0.93 10K:0.57rs144123929-CLipid or lipoprotein measurementCholesteryl esters to total lipids ratio in IDL0.08622261E-8GCST90092834European
6-32523760-C-TAFR:0.84 AMR:0.46 EAS:0.58 EUR:0.90 SAS:0.94 10K:0.70rs1613056-?Immune system disorderHypothyroidism or rheumatoid arthritis (pleiotropy)3E-99GCST90428109European
6-32528694-C-AAFR:0.84 AMR:0.46 EAS:0.58 EUR:0.92 SAS:0.94 10K:0.72rs1617322-?Immune system disorderHypothyroidism or rheumatoid arthritis (pleiotropy)3E-98GCST90428109European
6-32523477-G-AAFR:0.84 AMR:0.46 EAS:0.58 EUR:0.92 SAS:0.94 10K:0.70rs1794277-?Other measurementSeropositivity for streptococcus pneumoniae peptide (agilent_223208)10.1483E-24GCST90295773NR
6-32523477-G-AAFR:0.84 AMR:0.46 EAS:0.58 EUR:0.92 SAS:0.94 10K:0.70rs1794277-?Immune system disorderHypothyroidism or rheumatoid arthritis (pleiotropy)3E-99GCST90428109European
6-32522006-A-TAFR:0.84 AMR:0.46 EAS:0.58 EUR:0.92 SAS:0.94 10K:0.72rs1794280-TNROther measurementAnti-sp100 seropositivity in primary biliary cholangitis3.896E-28GCST007737East Asian
6-32522006-A-TAFR:0.84 AMR:0.46 EAS:0.58 EUR:0.92 SAS:0.94 10K:0.72rs1794280-TOther diseaseHyperthyroidism0.54632E-44GCST90018860European, East Asian
6-32522006-A-TAFR:0.84 AMR:0.46 EAS:0.58 EUR:0.92 SAS:0.94 10K:0.72rs1794280-?Immune system disorderHypothyroidism or rheumatoid arthritis (pleiotropy)1E-101GCST90428109European
6-32521193-C-TAFR:0.84 AMR:0.46 EAS:0.58 EUR:0.92 SAS:0.94 10K:0.73rs1794283-?Immune system disorderHypothyroidism or rheumatoid arthritis (pleiotropy)4E-101GCST90428109European
6-32526012-T-GAFR:0.84 AMR:0.46 EAS:0.58 EUR:0.92 SAS:0.94 10K:0.72rs1794511-GOther measurementIgD on IgD+ CD24+ B cell0.24397E-13GCST90001820European
6-32526012-T-GAFR:0.84 AMR:0.46 EAS:0.58 EUR:0.92 SAS:0.94 10K:0.72rs1794511-TOther traitAmiloride-sensitive amine oxidase [copper-containing] levels0.1329E-12GCST90246408European
6-32526012-T-GAFR:0.84 AMR:0.46 EAS:0.58 EUR:0.92 SAS:0.94 10K:0.72rs1794511-?Immune system disorderHypothyroidism or rheumatoid arthritis (pleiotropy)7E-99GCST90428109European
6-32517298-A-CAFR:0.84 AMR:0.46 EAS:0.58 EUR:0.90 SAS:0.94 10K:0.70rs1794519-?Immune system disorderHypothyroidism or rheumatoid arthritis (pleiotropy)1E-100GCST90428109European
6-32526605-T-GAFR:0.84 AMR:0.46 EAS:0.58 EUR:0.92 SAS:0.94 10K:0.72rs1794530-?Immune system disorderHypothyroidism or rheumatoid arthritis (pleiotropy)2E-99GCST90428109European
6-32522723-G-AAFR:0.84 AMR:0.46 EAS:0.58 EUR:0.92 SAS:0.94 10K:0.72rs2647044-ABRD2, BTNL2, C6orf10, HCG23, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DQB2, HLA-DRA, HLA-DRB1, HLA-DRB5, HLA-DRB6, LOC100294145, NOTCH4, PSMB8, PSMB9, TAP1, TAP2, TAPSAR1Other diseaseAsthma1.15221824E-15GCST008916European
6-32522723-G-AAFR:0.84 AMR:0.46 EAS:0.58 EUR:0.92 SAS:0.94 10K:0.72rs2647044-AHLA-DRB1Immune system disorderType 1 diabetes8.31E-16GCST000054European
6-32522723-G-AAFR:0.84 AMR:0.46 EAS:0.58 EUR:0.92 SAS:0.94 10K:0.72rs2647044-GHLA-DQB1Other measurementPulmonary function0.0446E-6GCST001248European
6-32522723-G-AAFR:0.84 AMR:0.46 EAS:0.58 EUR:0.92 SAS:0.94 10K:0.72rs2647044-?Other measurementSeropositivity for staphylococcus aureus peptide (agilent_226247)8.5691E-17GCST90295547NR
6-32522723-G-AAFR:0.84 AMR:0.46 EAS:0.58 EUR:0.92 SAS:0.94 10K:0.72rs2647044-?Other measurementSeropositivity for staphylococcus aureus peptide (agilent_222381)9.684E-22GCST90295549NR
6-32522723-G-AAFR:0.84 AMR:0.46 EAS:0.58 EUR:0.92 SAS:0.94 10K:0.72rs2647044-?Other measurementSeropositivity for staphylococcus aureus peptide (agilent_236333)8.915E-19GCST90295552NR
6-32522723-G-AAFR:0.84 AMR:0.46 EAS:0.58 EUR:0.92 SAS:0.94 10K:0.72rs2647044-?Other measurementSeropositivity for staphylococcaceae peptide (agilent_4825)9.3221E-20GCST90295458NR
6-32513786-A-GAFR:0.84 AMR:0.46 EAS:0.58 EUR:0.92 SAS:0.94 10K:0.72rs2856674-ABRD2Other measurementFeeling nervous6.412E-10GCST006948European
6-32513786-A-GAFR:0.84 AMR:0.46 EAS:0.58 EUR:0.92 SAS:0.94 10K:0.72rs2856674-?HLA-DQADigestive system disorderPrimary sclerosing cholangitis1E-6GCST006670European
6-32513786-A-GAFR:0.84 AMR:0.46 EAS:0.58 EUR:0.92 SAS:0.94 10K:0.72rs2856674-GMTCO3P1Body measurementA body shape index0.02978997E-14GCST90020024European
6-32513786-A-GAFR:0.84 AMR:0.46 EAS:0.58 EUR:0.92 SAS:0.94 10K:0.72rs2856674-GHematological measurementHemoglobin concentration0.051171E-22GCST90258652European
6-32499706-T-CAFR:0.84 AMR:0.46 EAS:0.60 EUR:0.92 SAS:0.94 10K:0.70rs3104361-THLA-DQB1Other measurementHelicobacter pylori OMP antibody levels0.187E-10GCST90006914European
6-32511584-T-CAFR:0.84 AMR:0.46 EAS:0.58 EUR:0.92 SAS:0.94 10K:0.72rs3129716-?HLA-DQB1Immune system disorderSystemic lupus erythematosus4E-9GCST003103European
6-32511584-T-CAFR:0.84 AMR:0.46 EAS:0.58 EUR:0.92 SAS:0.94 10K:0.72rs3129716-?Other measurementFAM3B/GUCA2A protein level ratio0.1661099E-66GCST90314779European
6-32511584-T-CAFR:0.84 AMR:0.46 EAS:0.58 EUR:0.92 SAS:0.94 10K:0.72rs3129716-?Other measurementHAVCR2/PILRA protein level ratio0.08356963E-18GCST90315028European
6-32511584-T-CAFR:0.84 AMR:0.46 EAS:0.58 EUR:0.92 SAS:0.94 10K:0.72rs3129716-?Other measurementHAVCR2/TNFRSF1B protein level ratio0.2041941E-102GCST90315030European
6-32511584-T-CAFR:0.84 AMR:0.46 EAS:0.58 EUR:0.92 SAS:0.94 10K:0.72rs3129716-?Other measurementITGA5/VCAM1 protein level ratio0.1108064E-30GCST90315206European
6-32511584-T-CAFR:0.84 AMR:0.46 EAS:0.58 EUR:0.92 SAS:0.94 10K:0.72rs3129716-?Other measurementFOLR2/HAVCR2 protein level ratio0.1650533E-69GCST90314865European
6-32511584-T-CAFR:0.84 AMR:0.46 EAS:0.58 EUR:0.92 SAS:0.94 10K:0.72rs3129716-?Other measurementCD300C/HAVCR2 protein level ratio0.1038232E-27GCST90313789European
6-32511584-T-CAFR:0.84 AMR:0.46 EAS:0.58 EUR:0.92 SAS:0.94 10K:0.72rs3129716-?Other measurementCDCP1/MSR1 protein level ratio0.1408934E-50GCST90313938European
6-32511584-T-CAFR:0.84 AMR:0.46 EAS:0.58 EUR:0.92 SAS:0.94 10K:0.72rs3129716-?Other measurementQPCT/RNASET2 protein level ratio0.3363819E-274GCST90315758European
6-32511584-T-CAFR:0.84 AMR:0.46 EAS:0.58 EUR:0.92 SAS:0.94 10K:0.72rs3129716-?Other measurementROBO2/SCARF2 protein level ratio0.07776294E-19GCST90315784European
6-32511584-T-CAFR:0.84 AMR:0.46 EAS:0.58 EUR:0.92 SAS:0.94 10K:0.72rs3129716-?Other measurementPLAUR/TREM2 protein level ratio0.1019062E-27GCST90315676European
6-32511584-T-CAFR:0.84 AMR:0.46 EAS:0.58 EUR:0.92 SAS:0.94 10K:0.72rs3129716-?Other measurementEFNA1/TNFRSF1A protein level ratio0.110868E-33GCST90314599European
6-32511584-T-CAFR:0.84 AMR:0.46 EAS:0.58 EUR:0.92 SAS:0.94 10K:0.72rs3129716-?Other measurementIGSF8/NECTIN2 protein level ratio0.1157341E-33GCST90315140European
6-32511584-T-CAFR:0.84 AMR:0.46 EAS:0.58 EUR:0.92 SAS:0.94 10K:0.72rs3129716-?Other measurementPIK3IP1/TNFRSF1A protein level ratio0.1280043E-40GCST90315653European
6-32511584-T-CAFR:0.84 AMR:0.46 EAS:0.58 EUR:0.92 SAS:0.94 10K:0.72rs3129716-?Other measurementADA2/COMP protein level ratio0.1811742E-80GCST90313166European
6-32511584-T-CAFR:0.84 AMR:0.46 EAS:0.58 EUR:0.92 SAS:0.94 10K:0.72rs3129716-?Other measurementADGRE2/SIGLEC1 protein level ratio0.09334043E-22GCST90313178European
6-32511584-T-CAFR:0.84 AMR:0.46 EAS:0.58 EUR:0.92 SAS:0.94 10K:0.72rs3129716-?Neurological disorderPolymyositis2.652E-54GCST90270217European
6-32501585-A-CAFR:0.84 AMR:0.46 EAS:0.60 EUR:0.92 SAS:0.94 10K:0.70rs3134971-COther traitCoiled-coil domain-containing protein 134 level in Chronic kidney disease with hypertension and no diabetes (15300_66)0.931E-21GCST90234306African American or Afro-Caribbean
6-32499069-G-TAFR:0.84 AMR:0.46 EAS:0.62 EUR:0.92 SAS:0.94 10K:0.71rs3134977-?Other measurementSeropositivity for staphylococcus aureus peptide (twist_46764)7.1757E-13GCST90295470NR
6-32498901-A-TAFR:0.84 AMR:0.46 EAS:0.62 EUR:0.92 SAS:0.94 10K:0.71rs3134978-AOther measurementGDNF family receptor alpha-1 levels0.178E-20GCST90247719European
6-32536438-C-TAFR:0.74 AMR:0.38 EAS:0.56 EUR:0.57 SAS:0.88 10K:0.65rs3957147-TNRImmune system disorderAutoimmune traits1.349E-9GCST011008European
6-32536438-C-TAFR:0.74 AMR:0.38 EAS:0.56 EUR:0.57 SAS:0.88 10K:0.65rs3957147-?Other measurementSeropositivity for streptococcus pneumoniae peptide (agilent_220951)5.8555E-9GCST90295790NR
6-32536438-C-TAFR:0.74 AMR:0.38 EAS:0.56 EUR:0.57 SAS:0.88 10K:0.65rs3957147-?Other measurementSeropositivity for streptococcus pneumoniae peptide (agilent_220944)6.2564E-10GCST90295776NR
6-32536438-C-TAFR:0.74 AMR:0.38 EAS:0.56 EUR:0.57 SAS:0.88 10K:0.65rs3957147-?Other measurementSeropositivity for streptococcus pneumoniae peptide (agilent_220184)6.4181E-10GCST90295777NR
6-32536438-C-TAFR:0.74 AMR:0.38 EAS:0.56 EUR:0.57 SAS:0.88 10K:0.65rs3957147-?Other measurementSeropositivity for streptococcus pneumoniae peptide (agilent_231039)5.6222E-8GCST90295781NR
6-32536438-C-TAFR:0.74 AMR:0.38 EAS:0.56 EUR:0.57 SAS:0.88 10K:0.65rs3957147-?Other measurementSeropositivity for hordeum vulgare (barley) peptide (twist_15602)5.6661E-8GCST90293451NR
6-32536438-C-TAFR:0.74 AMR:0.38 EAS:0.56 EUR:0.57 SAS:0.88 10K:0.65rs3957147-TXXbac-BPG254F23.7Body measurementHip circumference adjusted for BMI0.02328825E-9GCST012227European
6-32439175-G-CAFR:0.37 AMR:0.79 EAS:0.96 EUR:0.91 SAS:0.93 10K:0.81rs535777-?NRNeurological disorderHelp-seeking from a GP1.03626945E-6GCST010011European
6-32439175-G-CAFR:0.37 AMR:0.79 EAS:0.96 EUR:0.91 SAS:0.93 10K:0.81rs535777-GNRNeurological disorderHelp-seeking from a psychiatrist1.07526871E-9GCST010012European
6-32439175-G-CAFR:0.37 AMR:0.79 EAS:0.96 EUR:0.91 SAS:0.93 10K:0.81rs535777-?Other measurementDepression0.0119E-10GCST90239706European, NR
6-32439175-G-CAFR:0.37 AMR:0.79 EAS:0.96 EUR:0.91 SAS:0.93 10K:0.81rs535777-GCancerCancer (pleiotropy)(bidirectional)4E-12GCST90011823European
6-32533620-C-TAFR:0.84 AMR:0.46 EAS:0.58 EUR:0.90 SAS:0.94 10K:0.70rs9275576-THLA-DQA2Other measurementCoffee consumption (cups per day)0.0486E-9GCST010108European
6-32533620-C-TAFR:0.84 AMR:0.46 EAS:0.58 EUR:0.90 SAS:0.94 10K:0.70rs9275576-TOther measurementSecreted frizzled-related protein 3 levels0.1696E-18GCST90249516European
Epigenetic signals
MarkerCell typeRange
H3K27me3MG6332476849-32481112
Fixation index Fst
The Fixation index Fst was adopted as the measure for assessing population differences.